Page last updated: 2024-08-17

quinoxalines and probenecid

quinoxalines has been researched along with probenecid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, CP; Vartanian, MG1
Hansen, KT1
Löscher, W; Löschmann, PA; Richter, A1
Baltrons, MA; García, A; Pedraza, CE1
Chinen, LK; Dorshow, RB; Dyszlewski, ME; Galen, KP; Jacobs, FG; Kuan, KT; Ozaki, H; Pandurangi, RS; Rajagopalan, R; Sawai, H1
Aoki, T; Hashimoto, T; Kamimura, H; Minematsu, T; Usui, T1
Antic, SD; McKimm, EJ; Milosevic, MM; Singh, MB; White, JA1

Other Studies

7 other study(ies) available for quinoxalines and probenecid

ArticleYear
Probenecid pretreatment enhances anticonvulsant action of NBQX in mice.
    European journal of pharmacology, 1992, Mar-17, Volume: 213, Issue:1

    Topics: Animals; Anticonvulsants; Ataxia; Drug Synergism; Injections, Intravenous; Male; Mice; Motor Activity; Probenecid; Quinoxalines; Seizures

1992
Hepatic uptake and biliary excretion of the neuroprotectant 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline in rat liver. Involvement of an organic anion transport system.
    Biochemical pharmacology, 1995, Feb-14, Volume: 49, Issue:4

    Topics: Animals; Bile; Biological Transport; Dose-Response Relationship, Drug; Liver; Male; Perfusion; Probenecid; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA

1995
The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia.
    European journal of pharmacology, 1993, Feb-09, Volume: 231, Issue:2

    Topics: Animals; Cricetinae; Dystonia; Electric Stimulation; Excitatory Amino Acid Antagonists; Female; Injections, Intraperitoneal; Male; Mesocricetus; Probenecid; Quinoxalines; Receptors, AMPA; Solutions; Suspensions

1993
Interleukin-1beta stimulates cyclic GMP efflux in brain astrocytes.
    FEBS letters, 2001, Nov-02, Volume: 507, Issue:3

    Topics: Animals; Astrocytes; Biological Transport; Brain; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Interleukin-1; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxadiazoles; Probenecid; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Verapamil

2001
Fluorescence-enhanced europium-diethylenetriaminepentaacetic (DTPA)-monoamide complexes for the assessment of renal function.
    Journal of medicinal chemistry, 2008, Feb-28, Volume: 51, Issue:4

    Topics: Amides; Animals; Chelating Agents; Europium; Fluorescence; Glomerular Filtration Rate; Indium Radioisotopes; Ligands; Organometallic Compounds; Pentetic Acid; Probenecid; Quinoxalines; Radioisotopes; Rats; Rats, Sprague-Dawley; Samarium; Structure-Activity Relationship; Technetium; Tissue Distribution

2008
Role of organic anion transporters in the pharmacokinetics of zonampanel, an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, in rats.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:8

    Topics: Animals; Cell Line; Cimetidine; Excitatory Amino Acid Antagonists; Humans; Imidazoles; LLC-PK1 Cells; Male; Organic Anion Transporters; Probenecid; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Swine

2008
Mechanisms of Spontaneous Electrical Activity in the Developing Cerebral Cortex-Mouse Subplate Zone.
    Cerebral cortex (New York, N.Y. : 1991), 2019, 07-22, Volume: 29, Issue:8

    Topics: Action Potentials; Animals; Bicuculline; Calcium Channel Blockers; Calcium Signaling; Cerebral Cortex; Citrates; Connexin 26; Connexins; Ependymoglial Cells; Excitatory Amino Acid Antagonists; GABA-A Receptor Antagonists; Gadolinium; Gap Junction beta-1 Protein; Gap Junction delta-2 Protein; Gap Junctions; Glycine Agents; Hexachlorocyclohexane; Lanthanum; Mice; Neuroglia; Neurons; Octanols; Patch-Clamp Techniques; Probenecid; Pyridoxal Phosphate; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Strychnine; Valine; Vimentin

2019